D Edmund Anstey1, Shuang Li2, Laine Thomas2, Tracy Y Wang2, Stephen D Wiviott3. 1. Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts. 2. Cardiovascular Division, Department of Medicine, Duke Clinical Research Institute, Duke University, Durham, North Carolina. 3. Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts. swiviott@partners.org.
Abstract
BACKGROUND: Race and sex have been shown to affect management of myocardial infarction (MI); however, it is unclear if such disparities exist in contemporary care of ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). HYPOTHESIS: Disparities in care will be less prevalent in more heavily protocol-driven management of STEMI than the less algorithmic care of NSTEMI. METHODS: Data were collected from the ACTION Registry-GWTG database to assess care differences related to race and sex of patients presenting with NSTEMI or STEMI. For key treatments and outcomes, adjustments were made including patient demographics, baseline comorbidities, and markers of socioeconomic status. RESULTS: Key demographic variables demonstrate significant differences in baseline comorbidities; black patients had higher incidences of hypertension and diabetes, and women more frequently had diabetes. With few exceptions, rates of acute and discharge medical therapy were similar by race in any sex category in both STEMI and NSTEMI populations. Rates of catheterization were similar by race for STEMI but not for NSTEMI, where both black men and women had lower rates of invasive therapy. Rates of revascularization were significantly lower for black patients in both the STEMI and NSTEMI groups regardless of sex. Rates of adverse events differed by sex, with disparities for death and major bleeding; after adjustment, rates were similar by race within sex comparisons. CONCLUSIONS: In this contemporary cohort, although there are differences by race in presentation and management of MI, heavily protocol-driven processes seem to show fewer racial disparities.
BACKGROUND: Race and sex have been shown to affect management of myocardial infarction (MI); however, it is unclear if such disparities exist in contemporary care of ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI). HYPOTHESIS: Disparities in care will be less prevalent in more heavily protocol-driven management of STEMI than the less algorithmic care of NSTEMI. METHODS: Data were collected from the ACTION Registry-GWTG database to assess care differences related to race and sex of patients presenting with NSTEMI or STEMI. For key treatments and outcomes, adjustments were made including patient demographics, baseline comorbidities, and markers of socioeconomic status. RESULTS: Key demographic variables demonstrate significant differences in baseline comorbidities; black patients had higher incidences of hypertension and diabetes, and women more frequently had diabetes. With few exceptions, rates of acute and discharge medical therapy were similar by race in any sex category in both STEMI and NSTEMI populations. Rates of catheterization were similar by race for STEMI but not for NSTEMI, where both black men and women had lower rates of invasive therapy. Rates of revascularization were significantly lower for black patients in both the STEMI and NSTEMI groups regardless of sex. Rates of adverse events differed by sex, with disparities for death and major bleeding; after adjustment, rates were similar by race within sex comparisons. CONCLUSIONS: In this contemporary cohort, although there are differences by race in presentation and management of MI, heavily protocol-driven processes seem to show fewer racial disparities.
Authors: Alexandre C Pereira; Luz M Gomez; Marcio Sommer Bittencourt; Henrique Lane Staniak; Rodolfo Sharovsky; Murilo Foppa; Michael J Blaha; Isabela M Bensenor; Paulo A Lotufo Journal: Clin Cardiol Date: 2016-04-15 Impact factor: 2.882
Authors: Chee Tang Chin; Anita Y Chen; Tracy Y Wang; Karen P Alexander; Robin Mathews; John S Rumsfeld; Christopher P Cannon; Gregg C Fonarow; Eric D Peterson; Matthew T Roe Journal: Am Heart J Date: 2011-01 Impact factor: 4.749
Authors: S Weitzman; L Cooper; L Chambless; W Rosamond; L Clegg; G Marcucci; F Romm; A White Journal: Am J Cardiol Date: 1997-03-15 Impact factor: 2.778
Authors: Robin Mathews; Anita Y Chen; Laine Thomas; Tracy Y Wang; Chee Tang Chin; Kevin L Thomas; Matthew T Roe; Eric D Peterson Journal: Circulation Date: 2014-07-07 Impact factor: 29.690
Authors: Eric D Peterson; Bimal R Shah; Lori Parsons; Charles V Pollack; William J French; John G Canto; C Michael Gibson; William J Rogers Journal: Am Heart J Date: 2008-11-01 Impact factor: 4.749
Authors: Eric D Peterson; Matthew T Roe; John S Rumsfeld; Richard E Shaw; Ralph G Brindis; Gregg C Fonarow; Christopher P Cannon Journal: Circ Cardiovasc Qual Outcomes Date: 2009-09
Authors: Alexander R Green; Dana R Carney; Daniel J Pallin; Long H Ngo; Kristal L Raymond; Lisa I Iezzoni; Mahzarin R Banaji Journal: J Gen Intern Med Date: 2007-06-27 Impact factor: 5.128
Authors: Babikir Kheiri; Mohammed Osman; Ahmed Abdalla; Tarek Haykal; Bakr Swaid; Sahar Ahmed; Adam Chahine; Mustafa Hassan; Ghassan Bachuwa; Mohammed Al Qasmi; Deepak L Bhatt Journal: J Thromb Thrombolysis Date: 2019-02 Impact factor: 2.300
Authors: Rishi K Wadhera; Sameed Ahmed M Khatana; Eunhee Choi; Ginger Jiang; Changyu Shen; Robert W Yeh; Karen E Joynt Maddox Journal: JAMA Intern Med Date: 2020-03-01 Impact factor: 21.873
Authors: Lisandro D Colantonio; Keri L Monda; Robert S Rosenson; Todd M Brown; Katherine E Mues; George Howard; Monika M Safford; Larisa Yedigarova; Michael E Farkouh; Paul Muntner Journal: Cardiovasc Drugs Ther Date: 2019-04 Impact factor: 3.727
Authors: Dragana Radovanovic; Burkhardt Seifert; Marco Roffi; Philip Urban; Hans Rickli; Giovanni Pedrazzini; Paul Erne Journal: Open Heart Date: 2017-11-14
Authors: Mario Saia; Domenico Mantoan; Marco Fonzo; Chiara Bertoncello; Marta Soattin; Milena Sperotto; Tatjana Baldovin; Patrizia Furlan; Maria Luisa Scapellato; Guido Viel; Vincenzo Baldo; Silvia Cocchio; Alessandra Buja Journal: Int J Environ Res Public Health Date: 2018-09-11 Impact factor: 3.390
Authors: Jessica Potts; Alex Sirker; Sara C Martinez; Martha Gulati; Mirvat Alasnag; Muhammad Rashid; Chun Shing Kwok; Joie Ensor; Danielle L Burke; Richard D Riley; Lene Holmvang; Mamas A Mamas Journal: PLoS One Date: 2018-09-04 Impact factor: 3.240